The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1145
ISSUE1145
December 9, 2002
Adefovir (Hepsera) for Chronic Hepatitis B Infection
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Adefovir (Hepsera) for Chronic Hepatitis B Infection
December 9, 2002 (Issue: 1145)
Adefovir dipivoxil (Hepsera - Gilead), a nucleotide analog, has been approved by the FDA for oral treatment of chronic active infection with hepatitis B virus (HBV). In 1999, because of concerns about renal toxicity, the FDA rejected a higher-dosage...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.